SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD

Overview

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 23 active FDA Type II Drug Master Files, covering BALOXAVIR MARBOXIL; BIVALIRUDIN; CAGRILINTIDE; CETRORELIX ACETATE; DESMOPRESSIN ACETATE; DMT-2'FLUORO-DA(BZ) AMIDITE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD holds 23 active (26 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CAGRILINTIDEActive2026-03-26
• RETATRUTIDEActive2026-03-19
• SEMAGLUTIDE (SEMI-SYNTHETIC)Active2025-12-29
• RISDIPLAM INTERMEDIATE (CAS NO.: 2133298-74-3)Active2025-12-11
• SEMAGLUTIDEActive2025-12-01
• DMT-2'FLUORO-DA(BZ) AMIDITEActive2025-10-29
• ICOTROKINRAActive2025-08-29
• ORFORGLIPRONActive2025-04-27
• BALOXAVIR MARBOXILActive2025-04-18
• ELACESTRANT DIHYDROCHLORIDEActive2025-03-26
• RISDIPLAMActive2024-09-23
• TIRZEPATIDEActive2024-02-06
• DESMOPRESSIN ACETATEActive2023-01-16
• FULVESTRANT INTERMEDIATE (CAS NO.: 875573-66-3)Active2022-09-01
• SEMAGLUTIDEActive2021-11-01

Showing 15 of 26 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.